2000s
2000 On April 12, 2000, photodynamic therapy (PDT) with verteporfin (Visudyne®) is approved by the FDA for the treatment of neovascular AMD. Developed in the 1990s by Joan W. Miller, MD and Evangelos S. Gragoudas, MD, Visudyne® is the first pharmacologic treatment for retinal disease. From the...